Addex Therapeutics Ltd (ADXN) Reports In-Line Q2 EPS

Addex Therapeutics Ltd (NASDAQ: ADXN) reported Q2 EPS of ($0.04), in-line with the analyst estimate of ($0.04).

For earnings history and earnings-related data on Addex Therapeutics Ltd (ADXN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c